Biology of interleukin-10

Fiorentino, 1989, Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones, J Exp Med, 170, 2081, 10.1084/jem.170.6.2081 Kim, 1992, Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes, J Immunol, 148, 3618, 10.4049/jimmunol.148.11.3618 Josephson, 2001, Crystal structure of the IL-10/IL-10R1 complex reveals a shared receptor binding site, Immunity, 15, 35, 10.1016/S1074-7613(01)00169-8 Walter, 1995, Crystal structure of interleukin 10 reveals an interferon gamma-like fold, Biochemistry, 34, 12118, 10.1021/bi00038a004 Zdanov, 1995, Crystal structure of interleukin-10 reveals the functional dimer with an unexpected topological similarity to interferon gamma, Structure, 3, 591, 10.1016/S0969-2126(01)00193-9 Zdanov, 1996, Crystal structure of human interleukin-10 at 1.6A resolution and a model of a complex with its soluble receptor, Protein Sci, 5, 1955, 10.1002/pro.5560051001 Savan, 2009, Structural conservation of interferon gamma among vertebrates, Cytokine Growth Factor Rev, 20, 115, 10.1016/j.cytogfr.2009.02.006 Windsor, 1993, Disulfide bond assignments and secondary structure analysis of human and murine interleukin 10, Biochemistry, 32, 8807, 10.1021/bi00085a011 Moore, 2001, Interleukin-10 and the interleukin-10 receptor, Annu Rev Immunol, 19, 683, 10.1146/annurev.immunol.19.1.683 Zdanov, 1997, Crystal structure of Epstein–Barr virus protein BCRF1, a homolog of cellular interleukin-10, J Mol Biol, 268, 460, 10.1006/jmbi.1997.0990 Liu, 1997, The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor, J Immunol, 158, 604, 10.4049/jimmunol.158.2.604 Volk, 2001, IL-10 and its homologs: important immune mediators and emerging immunotherapeutic targets, Trends Immunol, 22, 414, 10.1016/S1471-4906(01)01985-8 Sabat, 2007, IL-19 and IL-20: two novel cytokines with importance in inflammatory diseases, Expert Opin Ther Targets, 11, 601, 10.1517/14728222.11.5.601 Wolk, 2006, Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells, Cytokine Growth Factor Rev, 17, 367, 10.1016/j.cytogfr.2006.09.001 Wolk, 2002, Cutting edge: immune cells as sources and targets of the IL-10 family members?, J Immunol, 168, 5397, 10.4049/jimmunol.168.11.5397 Murai, 2009, Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis, Nat Immunol, 10, 1178, 10.1038/ni.1791 Roers, 2004, T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation, J Exp Med, 200, 1289, 10.1084/jem.20041789 Seki, 1998, Role of liver NK cells and peritoneal macrophages in gamma interferon and interleukin-10 production in experimental bacterial peritonitis in mice, Infect Immun, 66, 5286, 10.1128/IAI.66.11.5286-5294.1998 Siewe, 2006, Interleukin-10 derived from macrophages and/or neutrophils regulates the inflammatory response to LPS but not the response to CpG DNA, Eur J Immunol, 36, 3248, 10.1002/eji.200636012 Blanco, 2008, Dendritic cells and cytokines in human inflammatory and autoimmune diseases, Cytokine Growth Factor Rev, 19, 41, 10.1016/j.cytogfr.2007.10.004 Chomarat, 1993, Interferon gamma inhibits interleukin 10 production by monocytes, J Exp Med, 177, 523, 10.1084/jem.177.2.523 Fillatreau, 2002, B cells regulate autoimmunity by provision of IL-10, Nat Immunol, 3, 944, 10.1038/ni833 Grant, 2008, Stat4-dependent, T-bet-independent regulation of IL-10 in NK cells, Genes Immun, 9, 316, 10.1038/gene.2008.20 Mehrotra, 1998, Production of IL-10 by human natural killer cells stimulated with IL-2 and/or IL-12, J Immunol, 160, 2637, 10.4049/jimmunol.160.6.2637 Rhodes, 2008, A subset of IL-10-producing gammadelta T cells protect the liver from Listeria-elicited, CD8(+) T cell-mediated injury, Eur J Immunol, 38, 2274, 10.1002/eji.200838354 Speiran, 2009, Endogenous suppression of mast cell development and survival by IL-4 and IL-10, J Leukoc Biol, 85, 826, 10.1189/jlb.0708448 Yanaba, 2009, The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals, J Immunol, 182, 7459, 10.4049/jimmunol.0900270 Zhang, 2009, Coactivation of Syk kinase and MyD88 adaptor protein pathways by bacteria promotes regulatory properties of neutrophils, Immunity, 31, 761, 10.1016/j.immuni.2009.09.016 Couper, 2008, IL-10: the master regulator of immunity to infection, J Immunol, 180, 5771, 10.4049/jimmunol.180.9.5771 Banerjee, 2006, Diverse Toll-like receptors utilize Tpl2 to activate extracellular signal-regulated kinase (ERK) in hemopoietic cells, Proc Natl Acad Sci USA, 103, 3274, 10.1073/pnas.0511113103 Hacker, 2006, Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6, Nature, 439, 204, 10.1038/nature04369 Meisel, 1996, Differential regulation of monocytic tumor necrosis factor-alpha and interleukin-10 expression, Eur J Immunol, 26, 1580, 10.1002/eji.1830260726 Platzer, 1995, Up-regulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs, Int Immunol, 7, 517, 10.1093/intimm/7.4.517 Suberville, 1996, Regulation of interleukin-10 production by beta-adrenergic agonists, Eur J Immunol, 26, 2601, 10.1002/eji.1830261110 Chung, 2007, Interleukin-10 expression in macrophages during phagocytosis of apoptotic cells is mediated by homeodomain proteins Pbx1 and Prep-1, Immunity, 27, 952, 10.1016/j.immuni.2007.11.014 Sharma, 2009, Posttranscriptional regulation of interleukin-10 expression by hsa-miR-106a, Proc Natl Acad Sci USA, 106, 5761, 10.1073/pnas.0808743106 Saraiva, 2009, Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose, Immunity, 31, 209, 10.1016/j.immuni.2009.05.012 Calado, 2006, Stochastic monoallelic expression of IL-10 in T cells, J Immunol, 177, 5358, 10.4049/jimmunol.177.8.5358 Ahyi, 2009, IFN regulatory factor 4 regulates the expression of a subset of Th2 cytokines, J Immunol, 183, 1598, 10.4049/jimmunol.0803302 Anderson, 2007, CD4(+)CD25(−)Foxp3(−) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis, J Exp Med, 204, 285, 10.1084/jem.20061886 Del Prete, 1993, Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production, J Immunol, 150, 353, 10.4049/jimmunol.150.2.353 Fitzgerald, 2007, Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells, Nat Immunol, 8, 1372, 10.1038/ni1540 Jankovic, 2007, Conventional T-bet(+)Foxp3(−) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection, J Exp Med, 204, 273, 10.1084/jem.20062175 Garcia, 2009, c-jun controls the ability of IL-12 to induce IL-10 production from human memory CD4+ T cells, J Immunol, 183, 4475, 10.4049/jimmunol.0901283 Anderson, 2009, IL-27 regulates IL-10 and IL-17 from CD4+ cells in nonhealing Leishmania major infection, J Immunol, 183, 4619, 10.4049/jimmunol.0804024 Stumhofer, 2007, Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10, Nat Immunol, 8, 1363, 10.1038/ni1537 Groux, 1997, A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis, Nature, 389, 737, 10.1038/39614 Batten, 2008, Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells, J Immunol, 180, 2752, 10.4049/jimmunol.180.5.2752 Murugaiyan, 2009, IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells, J Immunol, 183, 2435, 10.4049/jimmunol.0900568 Pot, 2009, Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells, J Immunol, 183, 797, 10.4049/jimmunol.0901233 Apetoh, 2010, The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27, Nat Immunol, 11, 854, 10.1038/ni.1912 Gandhi, 2010, Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells, Nat Immunol, 11, 846, 10.1038/ni.1915 Monteleone, 2009, Interleukin-21 (IL-21)-mediated pathways in T cell-mediated disease, Cytokine Growth Factor Rev, 20, 185, 10.1016/j.cytogfr.2009.02.002 Spolski, 2009, IL-21 mediates suppressive effects via its induction of IL-10, J Immunol, 182, 2859, 10.4049/jimmunol.0802978 Xu, 2009, c-Maf regulates IL-10 expression during Th17 polarization, J Immunol, 182, 6226, 10.4049/jimmunol.0900123 Gabrysova, 2009, Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells, J Exp Med, 206, 1755, 10.1084/jem.20082118 Haringer, 2009, Identification and characterization of IL-10/IFN-gamma-producing effector-like T cells with regulatory function in human blood, J Exp Med, 206, 1009, 10.1084/jem.20082238 Maynard, 2007, Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3− precursor cells in the absence of interleukin 10, Nat Immunol, 8, 931, 10.1038/ni1504 Denning, 2007, Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses, Nat Immunol, 8, 1086, 10.1038/ni1511 Littman, 2010, Th17 and regulatory T cells in mediating and restraining inflammation, Cell, 140, 845, 10.1016/j.cell.2010.02.021 Maynard, 2009, Contrasting roles for all-trans retinoic acid in TGF-beta-mediated induction of Foxp3 and Il10 genes in developing regulatory T cells, J Exp Med, 206, 343, 10.1084/jem.20080950 Brandenburg, 2008, IL-2 induces in vivo suppression by CD4(+)CD25(+)Foxp3(+) regulatory T cells, Eur J Immunol, 38, 1643, 10.1002/eji.200737791 Tsuji-Takayama, 2008, The production of IL-10 by human regulatory T cells is enhanced by IL-2 through a STAT5-responsive intronic enhancer in the IL-10 locus, J Immunol, 181, 3897, 10.4049/jimmunol.181.6.3897 McLachlan, 2009, Dendritic cell antigen presentation drives simultaneous cytokine production by effector and regulatory T cells in inflamed skin, Immunity, 30, 277, 10.1016/j.immuni.2008.11.013 Zhang, 2009, Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response, Immunity, 30, 458, 10.1016/j.immuni.2008.12.022 Vanden Eijnden, 2005, IL-23 up-regulates IL-10 and induces IL-17 synthesis by polyclonally activated naive T cells in human, Eur J Immunol, 35, 469, 10.1002/eji.200425677 McGeachy, 2007, TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology, Nat Immunol, 8, 1390, 10.1038/ni1539 Wolk, 2010, Biology of interleukin-22, Semin Immunopathol, 32, 17, 10.1007/s00281-009-0188-x Diveu, 2009, IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells, J Immunol, 182, 5748, 10.4049/jimmunol.0801162 de Waal Malefyt, 1991, Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes, J Exp Med, 174, 1209, 10.1084/jem.174.5.1209 Frasca, 2008, IFN-gamma arms human dendritic cells to perform multiple effector functions, J Immunol, 180, 1471, 10.4049/jimmunol.180.3.1471 Rivino, 2010, CCR6 is expressed on an IL-10-producing, autoreactive memory T cell population with context-dependent regulatory function, J Exp Med, 207, 565, 10.1084/jem.20091021 Kotenko, 2002, The family of IL-10-related cytokines and their receptors: related, but to what extent?, Cytokine Growth Factor Rev, 13, 223, 10.1016/S1359-6101(02)00012-6 Ho, 1993, A receptor for interleukin 10 is related to interferon receptors, Proc Natl Acad Sci USA, 90, 11267, 10.1073/pnas.90.23.11267 Liu, 1994, Expression cloning and characterization of a human IL-10 receptor, J Immunol, 152, 1821, 10.4049/jimmunol.152.4.1821 Taniyama, 1995, The human interleukin-10 receptor gene maps to chromosome 11q23.3, Hum Genet, 95, 99, 10.1007/BF00225083 Gasche, 2003, Novel variants of the IL-10 receptor 1 affect inhibition of monocyte TNF-alpha production, J Immunol, 170, 5578, 10.4049/jimmunol.170.11.5578 Hofer, 2005, Bi-allelic presence of the interleukin-10 receptor 1 G330R allele is associated with cirrhosis in chronic HCV-1 infection, Genes Immun, 6, 242, 10.1038/sj.gene.6364168 Kotenko, 1997, Identification and functional characterization of a second chain of the interleukin-10 receptor complex, EMBO J, 16, 5894, 10.1093/emboj/16.19.5894 Reineke, 1999, Evidence for conformationally different states of interleukin-10: binding of a neutralizing antibody enhances accessibility of a hidden epitope, J Mol Recognit, 12, 242, 10.1002/(SICI)1099-1352(199907/08)12:4<242::AID-JMR461>3.0.CO;2-1 Wolk, 2005, Is there an interaction between interleukin-10 and interleukin-22?, Genes Immun, 6, 8, 10.1038/sj.gene.6364144 Yoon, 2006, Conformational changes mediate interleukin-10 receptor 2 (IL-10R2) binding to IL-10 and assembly of the signaling complex, J Biol Chem, 281, 35088, 10.1074/jbc.M606791200 Logsdon, 2002, Comparison of interleukin-22 and interleukin-10 soluble receptor complexes, J Interferon Cytokine Res, 22, 1099, 10.1089/10799900260442520 Reineke, 1998, Mapping of the interleukin-10/interleukin-10 receptor combining site, Protein Sci, 7, 951, 10.1002/pro.5560070412 Yoon, 2010, Structure and mechanism of receptor sharing by the IL-10R2 common chain, Structure, 18, 638, 10.1016/j.str.2010.02.009 Carson, 1995, The functional characterization of interleukin-10 receptor expression on human natural killer cells, Blood, 85, 3577, 10.1182/blood.V85.12.3577.bloodjournal85123577 Jurlander, 1997, Characterization of interleukin-10 receptor expression on B-cell chronic lymphocytic leukemia cells, Blood, 89, 4146, 10.1182/blood.V89.11.4146 Kunz, 2006, Interleukin (IL)-19, IL-20 and IL-24 are produced by and act on keratinocytes and are distinct from classical ILs, Exp Dermatol, 15, 991, 10.1111/j.1600-0625.2006.00516.x Wolk, 2008, Maturing dendritic cells are an important source of IL-29 and IL-20 that may cooperatively increase the innate immunity of keratinocytes, J Leukoc Biol, 83, 1181, 10.1189/jlb.0807525 Wolk, 2004, IL-22 increases the innate immunity of tissues, Immunity, 21, 241, 10.1016/j.immuni.2004.07.007 Geginat, 2001, Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells, J Exp Med, 194, 1711, 10.1084/jem.194.12.1711 Seifert, 2003, Keratinocyte unresponsiveness towards interleukin-10: lack of specific binding due to deficient IL-10 receptor 1 expression, Exp Dermatol, 12, 137, 10.1034/j.1600-0625.2003.120203.x Weber-Nordt, 1994, Lipopolysaccharide-dependent induction of IL-10 receptor expression on murine fibroblasts, J Immunol, 153, 3734, 10.4049/jimmunol.153.8.3734 Crepaldi, 2001, Up-regulation of IL-10R1 expression is required to render human neutrophils fully responsive to IL-10, J Immunol, 167, 2312, 10.4049/jimmunol.167.4.2312 Ding, 2001, Differential IL-10R1 expression plays a critical role in IL-10-mediated immune regulation, J Immunol, 167, 6884, 10.4049/jimmunol.167.12.6884 Wolk, 2009, IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not, J Mol Med, 87, 523, 10.1007/s00109-009-0457-0 Kotenko, 2003, IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex, Nat Immunol, 4, 69, 10.1038/ni875 Sheikh, 2004, Cutting edge: IL-26 signals through a novel receptor complex composed of IL-20 receptor 1 and IL-10 receptor 2, J Immunol, 172, 2006, 10.4049/jimmunol.172.4.2006 Sheppard, 2003, IL-28, IL-29 and their class II cytokine receptor IL-28R, Nat Immunol, 4, 63, 10.1038/ni873 Xie, 2000, Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R, J Biol Chem, 275, 31335, 10.1074/jbc.M005304200 Gough, 2008, IFNgamma signaling—does it mean JAK-STAT?, Cytokine Growth Factor Rev, 19, 383, 10.1016/j.cytogfr.2008.08.004 Finbloom, 1995, IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes, J Immunol, 155, 1079, 10.4049/jimmunol.155.3.1079 Weber-Nordt, 1996, Stat3 recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the interleukin-10 receptor intracellular domain, J Biol Chem, 271, 27954, 10.1074/jbc.271.44.27954 Wehinger, 1996, IL-10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes, FEBS Lett, 394, 365, 10.1016/0014-5793(96)00990-8 Haan, 2000, Cytoplasmic STAT proteins associate prior to activation, Biochem J, 345, 417, 10.1042/0264-6021:3450417 Kretzschmar, 2004, Analysis of Stat3 (signal transducer and activator of transcription 3) dimerization by fluorescence resonance energy transfer in living cells, Biochem J, 377, 289, 10.1042/bj20030708 Novak, 1998, STAT3 forms stable homodimers in the presence of divalent cations prior to activation, Biochem Biophys Res Commun, 247, 558, 10.1006/bbrc.1998.8829 Schroder, 2004, Preassociation of nonactivated STAT3 molecules demonstrated in living cells using bioluminescence resonance energy transfer: a new model of STAT activation?, J Leukoc Biol, 75, 792, 10.1189/jlb.1003496 Piessevaux, 2008, The many faces of the SOCS box, Cytokine Growth Factor Rev, 19, 371, 10.1016/j.cytogfr.2008.08.006 Ito, 1999, Interleukin-10 inhibits expression of both interferon alpha- and interferon gamma-induced genes by suppressing tyrosine phosphorylation of STAT1, Blood, 93, 1456, 10.1182/blood.V93.5.1456 Riley, 1999, Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action, J Biol Chem, 274, 16513, 10.1074/jbc.274.23.16513 Crawley, 1996, Interleukin-10 stimulation of phosphatidylinositol 3-kinase and p70 S6 kinase is required for the proliferative but not the antiinflammatory effects of the cytokine, J Biol Chem, 271, 16357, 10.1074/jbc.271.27.16357 Ho, 1995, Functional regions of the mouse interleukin-10 receptor cytoplasmic domain, Mol Cell Biol, 15, 5043, 10.1128/MCB.15.9.5043 Jung, 2004, Expression profiling of IL-10-regulated genes in human monocytes and peripheral blood mononuclear cells from psoriatic patients during IL-10 therapy, Eur J Immunol, 34, 481, 10.1002/eji.200324323 Fiorentino, 1991, IL-10 inhibits cytokine production by activated macrophages, J Immunol, 147, 3815, 10.4049/jimmunol.147.11.3815 Hart, 1996, Regulation of surface and soluble TNF receptor expression on human monocytes and synovial fluid macrophages by IL-4 and IL-10, J Immunol, 157, 3672, 10.4049/jimmunol.157.8.3672 Jenkins, 1994, The effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1 beta production in human monocytes and neutrophils, Lymphokine Cytokine Res, 13, 47 Joyce, 1994, Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes, Eur J Immunol, 24, 2699, 10.1002/eji.1830241119 Kruglov, 2008, Physiological functions of tumor necrosis factor and the consequences of its pathologic overexpression or blockade: mouse models, Cytokine Growth Factor Rev, 19, 231, 10.1016/j.cytogfr.2008.04.010 Creery, 1996, Differential modulation of B7-1 and B7-2 isoform expression on human monocytes by cytokines which influence the development of T helper cell phenotype, Eur J Immunol, 26, 1273, 10.1002/eji.1830260614 de Waal Malefyt, 1991, Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression, J Exp Med, 174, 915, 10.1084/jem.174.4.915 Willems, 1994, Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes, Eur J Immunol, 24, 1007, 10.1002/eji.1830240435 D’Andrea, 1993, Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells, J Exp Med, 178, 1041, 10.1084/jem.178.3.1041 Billiau, 2009, Interferon-gamma: a historical perspective, Cytokine Growth Factor Rev, 20, 97, 10.1016/j.cytogfr.2009.02.004 Schuetze, 2005, IL-12 family members: differential kinetics of their TLR4-mediated induction by Salmonella enteritidis and the impact of IL-10 in bone marrow-derived macrophages, Int Immunol, 17, 649, 10.1093/intimm/dxh247 Buchwald, 1999, Interleukin-10: effects on phagocytosis and adhesion molecule expression of granulocytes and monocytes in a comparison with prednisolone, Eur J Med Res, 4, 85 Calzada-Wack, 1996, Interleukin-10 drives human monocytes to CD16 positive macrophages, J Inflamm, 46, 78 Spittler, 1995, IL-10 augments CD23 expression on U937 cells and down-regulates IL-4-driven CD23 expression on cultured human blood monocytes: effects of IL-10 and other cytokines on cell phenotype and phagocytosis, Immunology, 85, 311 te Velde, 1992, IL-10 stimulates monocyte Fc gamma R surface expression and cytotoxic activity. Distinct regulation of antibody-dependent cellular cytotoxicity by IFN-gamma, IL-4, and IL-10, J Immunol, 149, 4048, 10.4049/jimmunol.149.12.4048 Roilides, 1998, Suppressive effects of interleukin-10 on human mononuclear phagocyte function against Candida albicans and Staphylococcus aureus, J Infect Dis, 178, 1734, 10.1086/314479 Koch, 2009, IL-10 protects monocytes and macrophages from complement-mediated lysis, J Leukoc Biol, 86, 155, 10.1189/jlb.0708443 Vicioso, 1998, Moderate inhibitory effect of interleukin-10 on human neutrophil and monocyte chemotaxis in vitro, Eur Cytokine Netw, 9, 247 Allavena, 1998, IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages, Eur J Immunol, 28, 359, 10.1002/(SICI)1521-4141(199801)28:01<359::AID-IMMU359>3.0.CO;2-4 Schoenbein, 2008, Long-term interleukin-10 presence induces the development of a novel, monocyte-derived cell type, Clin Exp Immunol, 151, 306, 10.1111/j.1365-2249.2007.03554.x Fitzgerald-Bocarsly, 2008, Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history, Cytokine Growth Factor Rev, 19, 3, 10.1016/j.cytogfr.2007.10.006 Duramad, 2003, IL-10 regulates plasmacytoid dendritic cell response to CpG-containing immunostimulatory sequences, Blood, 102, 4487, 10.1182/blood-2003-07-2465 Waibler, 2008, Excessive CpG 1668 stimulation triggers IL-10 production by cDC that inhibits IFN-alpha responses by pDC, Eur J Immunol, 38, 3127, 10.1002/eji.200838184 Groux, 1996, Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells, J Exp Med, 184, 19, 10.1084/jem.184.1.19 Naundorf, 2009, IL-10 interferes directly with TCR-induced IFN-gamma but not IL-17 production in memory T cells, Eur J Immunol, 39, 1066, 10.1002/eji.200838773 Groux, 1998, Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells, J Immunol, 160, 3188, 10.4049/jimmunol.160.7.3188 Kemper, 2003, Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype, Nature, 421, 388, 10.1038/nature01315 Baecher-Allan, 2004, Human CD4+CD25+ regulatory T cells, Semin Immunol, 16, 89, 10.1016/j.smim.2003.12.005 Ito, 2008, Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery, Immunity, 28, 870, 10.1016/j.immuni.2008.03.018 Collison, 2009, Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35- and IL-10-dependent manner, J Immunol, 182, 6121, 10.4049/jimmunol.0803646 Rubtsov, 2008, Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces, Immunity, 28, 546, 10.1016/j.immuni.2008.02.017 Cassatella, 1993, Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide, J Exp Med, 178, 2207, 10.1084/jem.178.6.2207 Kasama, 1994, Regulation of neutrophil-derived chemokine expression by IL-10, J Immunol, 152, 3559, 10.4049/jimmunol.152.7.3559 Niiro, 1997, Regulation by interleukin-10 and interleukin-4 of cyclooxygenase-2 expression in human neutrophils, Blood, 89, 1621, 10.1182/blood.V89.5.1621 Takanaski, 1994, Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils, J Exp Med, 180, 711, 10.1084/jem.180.2.711 Keel, 1997, Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis, Blood, 90, 3356, 10.1182/blood.V90.9.3356 Arock, 1996, Interleukin-10 inhibits cytokine generation from mast cells, Eur J Immunol, 26, 166, 10.1002/eji.1830260126 Lin, 1997, Differential regulation of mast cell function by IL-10 and stem cell factor, J Immunol, 159, 4015, 10.4049/jimmunol.159.8.4015 Kennedy Norton, 2008, IL-10 suppresses mast cell IgE receptor expression and signaling in vitro and in vivo, J Immunol, 180, 2848, 10.4049/jimmunol.180.5.2848 Burdin, 1997, B-cell-derived IL-10: production and function, Methods, 11, 98, 10.1006/meth.1996.0393 Go, 1990, Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells, J Exp Med, 172, 1625, 10.1084/jem.172.6.1625 Levy, 1994, Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein, J Clin Invest, 93, 424, 10.1172/JCI116977 Rousset, 1995, Long-term cultured CD40-activated B lymphocytes differentiate into plasma cells in response to IL-10 but not IL-4, Int Immunol, 7, 1243, 10.1093/intimm/7.8.1243 Vieira, 1991, Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein–Barr virus open reading frame BCRFI, Proc Natl Acad Sci USA, 88, 1172, 10.1073/pnas.88.4.1172 Gruber, 2008, Differential signaling of cmvIL-10 through common variants of the IL-10 receptor 1, Eur J Immunol, 38, 3365, 10.1002/eji.200837718 Takeda, 1999, Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils, Immunity, 10, 39, 10.1016/S1074-7613(00)80005-9 El Kasmi, 2006, General nature of the STAT3-activated anti-inflammatory response, J Immunol, 177, 7880, 10.4049/jimmunol.177.11.7880 Williams, 2004, Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages, J Immunol, 172, 567, 10.4049/jimmunol.172.1.567 Minegishi, 2007, Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome, Nature, 448, 1058, 10.1038/nature06096 Woellner, 2010, Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome, J Allergy Clin Immunol, 125, 424, 10.1016/j.jaci.2009.10.059 Rossato, 2007, IL-10 modulates cytokine gene transcription by protein synthesis-independent and dependent mechanisms in lipopolysaccharide-treated neutrophils, Eur J Immunol, 37, 3176, 10.1002/eji.200737625 Lang, 2002, Shaping gene expression in activated and resting primary macrophages by IL-10, J Immunol, 169, 2253, 10.4049/jimmunol.169.5.2253 Williams, 2002, IL-10 expression profiling in human monocytes, J Leukoc Biol, 72, 800, 10.1189/jlb.72.4.800 Basak, 2008, Crosstalk via the NF-kappaB signaling system, Cytokine Growth Factor Rev, 19, 187, 10.1016/j.cytogfr.2008.04.005 Schmid, 2008, IkappaB kinase beta (IKKbeta/IKK2/IKBKB)—a key molecule in signaling to the transcription factor NF-kappaB, Cytokine Growth Factor Rev, 19, 157, 10.1016/j.cytogfr.2008.01.006 Wertz, 2008, Ubiquitin-mediated regulation of TNFR1 signaling, Cytokine Growth Factor Rev, 19, 313, 10.1016/j.cytogfr.2008.04.014 Grutz, 2005, New insights into the molecular mechanism of interleukin-10-mediated immunosuppression, J Leukoc Biol, 77, 3, 10.1189/jlb.0904484 Baetz, 2004, Suppressor of cytokine signaling (SOCS) proteins indirectly regulate toll-like receptor signaling in innate immune cells, J Biol Chem, 279, 54708, 10.1074/jbc.M410992200 Gingras, 2004, Re-examination of the role of suppressor of cytokine signaling 1 (SOCS1) in the regulation of toll-like receptor signaling, J Biol Chem, 279, 54702, 10.1074/jbc.M411043200 Nakagawa, 2002, SOCS-1 participates in negative regulation of LPS responses, Immunity, 17, 677, 10.1016/S1074-7613(02)00449-1 Croker, 2003, SOCS3 negatively regulates IL-6 signaling in vivo, Nat Immunol, 4, 540, 10.1038/ni931 Lang, 2003, SOCS3 regulates the plasticity of gp130 signaling, Nat Immunol, 4, 546, 10.1038/ni932 Yasukawa, 2003, IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages, Nat Immunol, 4, 551, 10.1038/ni938 Hammer, 2005, Control of dual-specificity phosphatase-1 expression in activated macrophages by IL-10, Eur J Immunol, 35, 2991, 10.1002/eji.200526192 Chi, 2006, Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses, Proc Natl Acad Sci USA, 103, 2274, 10.1073/pnas.0510965103 Hammer, 2006, Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock, J Exp Med, 203, 15, 10.1084/jem.20051753 Salojin, 2006, Essential role of MAPK phosphatase-1 in the negative control of innate immune responses, J Immunol, 176, 1899, 10.4049/jimmunol.176.3.1899 Zhao, 2006, MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock, J Exp Med, 203, 131, 10.1084/jem.20051794 Dagvadorj, 2008, Interleukin-10 inhibits tumor necrosis factor-alpha production in lipopolysaccharide-stimulated RAW 264.7 cells through reduced MyD88 expression, Innate Immun, 14, 109, 10.1177/1753425908089618 Chang, 2009, Negative regulation of MyD88-dependent signaling by IL-10 in dendritic cells, Proc Natl Acad Sci USA, 106, 18327, 10.1073/pnas.0905815106 McCoy, 2010, IL-10 inhibits miR-155 induction by toll-like receptors, J Biol Chem, 285, 20492, 10.1074/jbc.M110.102111 O’Connell, 2009, Inositol phosphatase SHIP1 is a primary target of miR-155, Proc Natl Acad Sci USA, 106, 7113, 10.1073/pnas.0902636106 Sly, 2004, LPS-induced upregulation of SHIP is essential for endotoxin tolerance, Immunity, 21, 227, 10.1016/j.immuni.2004.07.010 Murray, 2005, The primary mechanism of the IL-10-regulated antiinflammatory response is to selectively inhibit transcription, Proc Natl Acad Sci USA, 102, 8686, 10.1073/pnas.0500419102 Driessler, 2004, Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappaB activity: a role for p50, Clin Exp Immunol, 135, 64, 10.1111/j.1365-2249.2004.02342.x Cao, 2006, NF-kappaB1 (p50) homodimers differentially regulate pro- and anti-inflammatory cytokines in macrophages, J Biol Chem, 281, 26041, 10.1074/jbc.M602222200 Kuwata, 2003, IL-10-inducible Bcl-3 negatively regulates LPS-induced TNF-alpha production in macrophages, Blood, 102, 4123, 10.1182/blood-2003-04-1228 Hirotani, 2005, The nuclear IkappaB protein IkappaBNS selectively inhibits lipopolysaccharide-induced IL-6 production in macrophages of the colonic lamina propria, J Immunol, 174, 3650, 10.4049/jimmunol.174.6.3650 Weaver, 2007, ABIN-3: a molecular basis for species divergence in interleukin-10-induced anti-inflammatory actions, Mol Cell Biol, 27, 4603, 10.1128/MCB.00223-07 El Kasmi, 2007, Cutting edge: a transcriptional repressor and corepressor induced by the STAT3-regulated anti-inflammatory signaling pathway, J Immunol, 179, 7215, 10.4049/jimmunol.179.11.7215 Muhlbauer, 2008, Impaired Bcl3 up-regulation leads to enhanced lipopolysaccharide-induced interleukin (IL)-23P19 gene expression in IL-10(−/−) mice, J Biol Chem, 283, 14182, 10.1074/jbc.M709029200 Bogdan, 1992, Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10, J Biol Chem, 267, 23301, 10.1016/S0021-9258(18)50091-0 Brown, 1996, Differential regulation of the stability of cytokine mRNAs in lipopolysaccharide-activated blood monocytes in response to interleukin-10, J Biol Chem, 271, 20108, 10.1074/jbc.271.33.20108 Kishore, 1999, Cutting edge: clustered AU-rich elements are the target of IL-10-mediated mRNA destabilization in mouse macrophages, J Immunol, 162, 2457, 10.4049/jimmunol.162.5.2457 Kontoyiannis, 2001, Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology, EMBO J, 20, 3760, 10.1093/emboj/20.14.3760 Denys, 2002, Evidence for a dual mechanism for IL-10 suppression of TNF-alpha production that does not involve inhibition of p38 mitogen-activated protein kinase or NF-kappa B in primary human macrophages, J Immunol, 168, 4837, 10.4049/jimmunol.168.10.4837 Gaestel, 2006, MAPKAP kinases – MKs – two's company, three's a crowd, Nat Rev Mol Cell Biol, 7, 120, 10.1038/nrm1834 Rajasingh, 2006, IL-10-induced TNF-alpha mRNA destabilization is mediated via IL-10 suppression of p38 MAP kinase activation and inhibition of HuR expression, FASEB J, 20, 2112, 10.1096/fj.06-6084fje Schaljo, 2009, Tristetraprolin is required for full anti-inflammatory response of murine macrophages to IL-10, J Immunol, 183, 1197, 10.4049/jimmunol.0803883 Krishnamurthy, 2010, Myocardial knockdown of mRNA-stabilizing protein HuR attenuates post-MI inflammatory response and left ventricular dysfunction in IL-10-null mice, FASEB J, 24, 2484, 10.1096/fj.09-149815 Koppelman, 1997, Interleukin-10 down-regulates MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling, Immunity, 7, 861, 10.1016/S1074-7613(00)80404-5 Thibodeau, 2008, Interleukin-10-induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes, Eur J Immunol, 38, 1225, 10.1002/eji.200737902 Schroder, 2003, Different modes of IL-10 and TGF-beta to inhibit cytokine-dependent IFN-gamma production: consequences for reversal of lipopolysaccharide desensitization, J Immunol, 170, 5260, 10.4049/jimmunol.170.10.5260 de Waal Malefyt, 1993, Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation, J Immunol, 150, 4754, 10.4049/jimmunol.150.11.4754 Joss, 2000, IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway, Eur J Immunol, 30, 1683, 10.1002/1521-4141(200006)30:6<1683::AID-IMMU1683>3.0.CO;2-A Grondal, 1999, Increased number of interleukin-10-producing cells in systemic lupus erythematosus patients and their first-degree relatives and spouses in Icelandic multicase families, Arthritis Rheum, 42, 1649, 10.1002/1529-0131(199908)42:8<1649::AID-ANR13>3.0.CO;2-D Stewart, 1994, Differential expression of viral and human interleukin-10 (IL-10) by primary B cell tumors and B cell lines, Virology, 200, 724, 10.1006/viro.1994.1236 Yue, 1997, Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules, Int J Cancer, 71, 630, 10.1002/(SICI)1097-0215(19970516)71:4<630::AID-IJC20>3.0.CO;2-E Salhi, 2008, Immunological and genetic evidence for a crucial role of IL-10 in cutaneous lesions in humans infected with Leishmania braziliensis, J Immunol, 180, 6139, 10.4049/jimmunol.180.9.6139 Berres, 2009, Longitudinal monocyte human leukocyte antigen-DR expression is a prognostic marker in critically ill patients with decompensated liver cirrhosis, Liver Int, 29, 536, 10.1111/j.1478-3231.2008.01870.x Docke, 1997, Monocyte deactivation in septic patients: restoration by IFN-gamma treatment, Nat Med, 3, 678, 10.1038/nm0697-678 Steinhauser, 1999, IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense, J Immunol, 162, 392, 10.4049/jimmunol.162.1.392 Woiciechowsky, 1998, Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury, Nat Med, 4, 808, 10.1038/nm0798-808 Wolk, 2000, Impaired antigen presentation by human monocytes during endotoxin tolerance, Blood, 96, 218, 10.1182/blood.V96.1.218 Wolk, 2007, Reduced monocyte CD86 expression in postinflammatory immunodeficiency, Crit Care Med, 35, 458, 10.1097/01.CCM.0000254724.54515.2F Chiu, 2008, Mononuclear phagocyte-derived IL-10 suppresses the innate IL-12/IFN-gamma axis in lung-challenged aged mice, J Immunol, 181, 3156, 10.4049/jimmunol.181.5.3156 Asadullah, 1998, IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach, J Clin Invest, 101, 783, 10.1172/JCI1476 DeBruyne, 1998, Lipid-mediated gene transfer of viral IL-10 prolongs vascularized cardiac allograft survival by inhibiting donor-specific cellular and humoral immune responses, Gene Ther, 5, 1079, 10.1038/sj.gt.3300694 Katsikis, 1994, Immunoregulatory role of interleukin 10 in rheumatoid arthritis, J Exp Med, 179, 1517, 10.1084/jem.179.5.1517 van Montfrans, 1998, Immunotherapy of Crohn's disease, Mediators Inflamm, 7, 149, 10.1080/09629359891063 Eskdale, 1997, Mapping of the human IL10 gene and further characterization of the 5′ flanking sequence, Immunogenetics, 46, 120, 10.1007/s002510050250 Smith, 2009, Cytokine and cytokine receptor gene polymorphisms and their functionality, Cytokine Growth Factor Rev, 20, 43, 10.1016/j.cytogfr.2008.11.006 Dutra, 2009, Implications of cytokine gene polymorphisms on the orchestration of the immune response: lessons learned from oral diseases, Cytokine Growth Factor Rev, 20, 223, 10.1016/j.cytogfr.2009.05.005 Larsson, 2009, The Sp1 transcription factor binds to the G-allele of the −1087 IL-10 gene polymorphism and enhances transcriptional activation, Genes Immun, 10, 280, 10.1038/gene.2008.79 Warle, 2003, Are cytokine gene polymorphisms related to in vitro cytokine production profiles?, Liver Transpl, 9, 170, 10.1053/jlts.2002.50014 Eskdale, 1997, Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus, Tissue Antigens, 49, 635, 10.1111/j.1399-0039.1997.tb02812.x Grundtner, 2009, The IL-10R1 S138G loss-of-function allele and ulcerative colitis, Genes Immun, 10, 84, 10.1038/gene.2008.72 Lazarus, 1997, Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus, J Rheumatol, 24, 2314 Oleksyk, 2009, Extended IL10 haplotypes and their association with HIV progression to AIDS, Genes Immun, 10, 309, 10.1038/gene.2009.9 Schoof, 2009, Distal and proximal interleukin (IL)-10 promoter polymorphisms associated with risk of cutaneous melanoma development: a case–control study, Genes Immun, 10, 586, 10.1038/gene.2009.40 Turner, 1997, Cytokine gene polymorphism and heart transplant rejection, Transplantation, 64, 776, 10.1097/00007890-199709150-00021 Chong, 2004, Association of interleukin-10 promoter polymorphisms with systemic lupus erythematosus, Genes Immun, 5, 484, 10.1038/sj.gene.6364119 Helminen, 1999, Polymorphism of the interleukin-10 gene is associated with susceptibility to Epstein–Barr virus infection, J Infect Dis, 180, 496, 10.1086/314883 Sankaran, 1999, Cytokine gene polymorphisms predict acute graft rejection following renal transplantation, Kidney Int, 56, 281, 10.1046/j.1523-1755.1999.00536.x Groux, 1999, A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells, J Immunol, 162, 1723, 10.4049/jimmunol.162.3.1723 Kuhn, 1993, Interleukin-10-deficient mice develop chronic enterocolitis, Cell, 75, 263, 10.1016/0092-8674(93)80068-P Glocker, 2009, Inflammatory bowel disease and mutations affecting the interleukin-10 receptor, N Engl J Med, 361, 2033, 10.1056/NEJMoa0907206 Berg, 1995, Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance, J Clin Invest, 96, 2339, 10.1172/JCI118290 Pils, 2010, Monocytes/macrophages and/or neutrophils are the target of IL-10 in the LPS endotoxemia model, Eur J Immunol, 40, 443, 10.1002/eji.200939592 Bettelli, 1998, IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice, J Immunol, 161, 3299, 10.4049/jimmunol.161.7.3299 Elliott, 2008, Colonization with Heligmosomoides polygyrus suppresses mucosal IL-17 production, J Immunol, 181, 2414, 10.4049/jimmunol.181.4.2414 Guilliams, 2009, IL-10 dampens TNF/inducible nitric oxide synthase-producing dendritic cell-mediated pathogenicity during parasitic infection, J Immunol, 182, 1107, 10.4049/jimmunol.182.2.1107 Herbert, 2008, IL-10 and TGF-beta redundantly protect against severe liver injury and mortality during acute schistosomiasis, J Immunol, 181, 7214, 10.4049/jimmunol.181.10.7214 Higgins, 2009, Lack of IL-10 alters inflammatory and immune responses during pulmonary Mycobacterium tuberculosis infection, Tuberculosis (Edinb), 89, 149, 10.1016/j.tube.2009.01.001 Igyarto, 2009, Langerhans cells suppress contact hypersensitivity responses via cognate CD4 interaction and langerhans cell-derived IL-10, J Immunol, 183, 5085, 10.4049/jimmunol.0901884 Johansson, 2001, IL-10-deficient B10.Q mice develop more severe collagen-induced arthritis, but are protected from arthritis induced with anti-type II collagen antibodies, J Immunol, 167, 3505, 10.4049/jimmunol.167.6.3505 Londono, 2008, IL-10 helps control pathogen load during high-level bacteremia, J Immunol, 181, 2076, 10.4049/jimmunol.181.3.2076 Madan, 2009, Nonredundant roles for B cell-derived IL-10 in immune counter-regulation, J Immunol, 183, 2312, 10.4049/jimmunol.0900185 Walsh, 2009, Infection with a helminth parasite attenuates autoimmunity through TGF-beta-mediated suppression of Th17 and Th1 responses, J Immunol, 183, 1577, 10.4049/jimmunol.0803803 Almeida, 2009, Tuberculosis is associated with a down-modulatory lung immune response that impairs Th1-type immunity, J Immunol, 183, 718, 10.4049/jimmunol.0801212 Anderson, 2008, IL-10 and TGF-beta control the establishment of persistent and transmissible infections produced by Leishmania tropica in C57BL/6 mice, J Immunol, 180, 4090, 10.4049/jimmunol.180.6.4090 Beamer, 2008, Interleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA/J mice, J Immunol, 181, 5545, 10.4049/jimmunol.181.8.5545 Belkaid, 2001, The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure, J Exp Med, 194, 1497, 10.1084/jem.194.10.1497 Brooks, 2008, IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection, J Exp Med, 205, 533, 10.1084/jem.20071948 Maroof, 2008, Posttranscriptional regulation of II10 gene expression allows natural killer cells to express immunoregulatory function, Immunity, 29, 295, 10.1016/j.immuni.2008.06.012 McKinstry, 2009, IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge, J Immunol, 182, 7353, 10.4049/jimmunol.0900657 Schreiber, 2009, Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunity, J Immunol, 183, 1301, 10.4049/jimmunol.0803567 Gottfried, 2008, Tumor-induced modulation of dendritic cell function, Cytokine Growth Factor Rev, 19, 65, 10.1016/j.cytogfr.2007.10.008 de Lemos Rieper, 2009, Characterization and potential clinical applications of autoantibodies against cytokines, Cytokine Growth Factor Rev, 20, 61, 10.1016/j.cytogfr.2009.01.003 Maeda, 2008, Experimental extracorporeal photopheresis inhibits the sensitization and effector phases of contact hypersensitivity via two mechanisms: generation of IL-10 and induction of regulatory T cells, J Immunol, 181, 5956, 10.4049/jimmunol.181.9.5956 Yang, 2000, IL-10 deficiency prevents IL-5 overproduction and eosinophilic inflammation in a murine model of asthma-like reaction, Eur J Immunol, 30, 382, 10.1002/1521-4141(200002)30:2<382::AID-IMMU382>3.0.CO;2-L Sun, 2010, A detrimental effect of interleukin-10 on protective pulmonary humoral immunity during primary influenza A virus infection, J Virol, 84, 5007, 10.1128/JVI.02408-09 Oakley, 2008, Increased weight loss with reduced viral replication in interleukin-10 knock-out mice infected with murine cytomegalovirus, Clin Exp Immunol, 151, 155, 10.1111/j.1365-2249.2007.03533.x Brooks, 2006, Interleukin-10 determines viral clearance or persistence in vivo, Nat Med, 12, 1301, 10.1038/nm1492 Penttilä, 2008, Chlamydia pneumoniae infection in IL-10 knock out mice: accelerated clearance but severe pulmonary inflammatory response, Microb Pathog, 45, 25, 10.1016/j.micpath.2008.02.004 Yang, 1999, IL-10 gene knockout mice show enhanced Th1-like protective immunity and absent granuloma formation following Chlamydia trachomatis lung infection, J Immunol, 162, 1010, 10.4049/jimmunol.162.2.1010 Murray, 1999, Increased antimycobacterial immunity in interleukin-10-deficient mice, Infect Immun, 67, 3087, 10.1128/IAI.67.6.3087-3095.1999 Sewnath, 2001, IL-10-deficient mice demonstrate multiple organ failure and increased mortality during Escherichia coli peritonitis despite an accelerated bacterial clearance, J Immunol, 166, 6323, 10.4049/jimmunol.166.10.6323 Vazquez-Torres, 1999, Early resistance of interleukin-10 knockout mice to acute systemic candidiasis, Infect Immun, 67, 670, 10.1128/IAI.67.2.670-674.1999 Gazzinelli, 1996, In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha, J Immunol, 157, 798, 10.4049/jimmunol.157.2.798 Wilson, 2005, A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis, J Neuroimmunol, 165, 63, 10.1016/j.jneuroim.2005.04.018 Anderson, 2005, Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice, J Immunol, 174, 2934, 10.4049/jimmunol.174.5.2934 Li, 1999, A defect in interleukin-10 leads to enhanced malarial disease in Plasmodium chabaudi chabaudi infection in mice, Infect Immun, 67, 4435, 10.1128/IAI.67.9.4435-4442.1999 Li, 2003, Pathology of Plasmodium chabaudi chabaudi infection and mortality in interleukin-10-deficient mice are ameliorated by anti-tumor necrosis factor alpha and exacerbated by anti-transforming growth factor beta antibodies, Infect Immun, 71, 4850, 10.1128/IAI.71.9.4850-4856.2003 Sanni, 2004, Cerebral edema and cerebral hemorrhages in interleukin-10-deficient mice infected with Plasmodium chabaudi, Infect Immun, 72, 3054, 10.1128/IAI.72.5.3054-3058.2004 Holscher, 2000, Tumor necrosis factor alpha-mediated toxic shock in Trypanosoma cruzi-infected interleukin 10-deficient mice, Infect Immun, 68, 4075, 10.1128/IAI.68.7.4075-4083.2000 Hunter, 1997, IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi, J Immunol, 158, 3311, 10.4049/jimmunol.158.7.3311 Wynn, 1998, IL-10 regulates liver pathology in acute murine Schistosomiasis mansoni but is not required for immune down-modulation of chronic disease, J Immunol, 160, 4473, 10.4049/jimmunol.160.9.4473 Sadler, 2003, IL-10 is crucial for the transition from acute to chronic disease state during infection of mice with Schistosoma mansoni, Eur J Immunol, 33, 880, 10.1002/eji.200323501